EKF Diagnostics Investor Announcements

EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.

20th Sep 2022

Dividend Timetable

20th Sep 2022

Half-year Report


Notice of Results


Strong double-digit growth in underlying (non-COVID) revenue

TR-1: Standard form for notification of major holdings

Purchase of shares in EKF Diagnostics Holdings plc.

Approval of dividend in specie of investment in Verici Dx plc

EKF Diagnostics provides an update following the strengthening of its cash position.

9th Jun 2022

Enabling hospitals, labs and GPs to manage and evaluate patient data easily and securely

EKF announces the completion of the Company’s buyback programme


  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Mount Sinai investments related

RNS announcements